Growdea technologies received support from Kisankraft to conduct a research titled “Development of a Novel Peptide Therapy for COVID-19”. This project, being carried out at DBT Centre of Excellence for Biopharmaceutical Technology, IIT Delhi, is utilizing bioinformatics tools to design a novel peptide for blocking coronavirus. They are being supported in their endeavour by Kisankraft Limited. The IIT Delhi-based startup Growdea Technologies Pvt. Ltd is founded by Dr Avinash Mishra at IIT Delhi.